- WORLD EDITIONAustraliaNorth AmericaWorld
Canadian Zeolite (TSXV:CNZ) (OTCQB:CNZCF) (FSE:ZEON) has announced it has reached an agreement with Isodiol, a Southern California-based hemp Cannabidiol “CBD” innovator. Canadian Zeolite will now be working with Isodiol to research and develop CBD and Zeolite infused products and supplements intended for human and animal consumption. As quoted in the press release: In Isodiol’s state …
Canadian Zeolite (TSXV:CNZ) (OTCQB:CNZCF) (FSE:ZEON) has announced it has reached an agreement with Isodiol, a Southern California-based hemp Cannabidiol “CBD” innovator. Canadian Zeolite will now be working with Isodiol to research and develop CBD and Zeolite infused products and supplements intended for human and animal consumption.
As quoted in the press release:
In Isodiol’s state of the art facilities in Southern California, the zeolite will be micronized maintaining its optimal cell structure to be combined with hemp derived CBD and other adaptogenic herbs. This will then be infused into a complete line of products designed towards human consumption, including a full line of anti-aging skin care products as well as products designed for animal consumption.
Isodiol’s Chief Operating Officer, Troy Nihart, stated, “Isodiol is looking forward to introducing these new products to the marketplace. Zeolite as an additive, has tremendous potential especially with its detoxification properties. We feel there is an undiscovered zeolite market which we can develop and are very excited to begin a partnership with Canadian Zeolite.”
The Conversation (0)
Latest News
Outlook Reports
Featured Stocks
Browse Companies
MARKETS
COMMODITIES
CURRENCIES